Literature DB >> 20665943

Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.

Jean-Sébastien Casalegno1, Maude Bouscambert-Duchamp, Valérie Caro, Isabelle Schuffenecker, Murielle Sabatier, Aurélien Traversier, Martine Valette, Bruno Lina, Olivier Ferraris, Vanessa Escuret.   

Abstract

Influenza A(H1N1) viruses resistant to oseltamivir carboxylate (OC) emerged in 2007/2008 in the absence of antiviral pressure. These OC-resistant A(H1N1) viruses had a better fitness than the sensitive ones as they were 100% prevalent in 2008/2009. To better understand the role of the neuraminidase (NA) affinity in the emergence of these OC-resistant A(H1N1) viruses we compared the NA properties among A(H1N1) clinical isolates in south of France between 2005 and 2009 and reference strains from 1977 to 2007, using NA inhibition assays, kinetic analyses of NA activities, and sequence analysis of viral NA and hemagglutinin (HA). In 2007/2008, among 374 A(H1N1) isolates tested, 38% were resistant to OC with a mean IC50 of 564+/-357 nM. The mean Km of OC-sensitive isolates (H275) was significantly lower (22.6+/- 4.7 microM) than the Km of previous reference strains (44.9+/- 5 microM) and the mean Km of the OC-resistant isolates (Y275) (37.2 +/- 7.7 microM). The combination of different amino acid mutations in N1 particularly the D344N could explain the higher NA affinity of A/Brisbane/59/2007 related variants compared to the previous A(H1N1) strains and the H275Y mutation allowed to retrieve Km values near 40 microM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665943     DOI: 10.1016/j.antiviral.2010.05.010

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Emerging influenza antiviral resistance threats.

Authors:  Frederick G Hayden; Menno D de Jong
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

2.  Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase.

Authors:  Nicole M Bouvier; Saad Rahmat; Natalie Pica
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.

Authors:  Mathilde Richard; Olivier Ferraris; Alexandra Erny; Mendy Barthélémy; Aurélien Traversier; Murielle Sabatier; Alan Hay; Yi Pu Lin; Rupert J Russell; Bruno Lina
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

4.  Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009.

Authors:  Ji-Rong Yang; Yu-Cheng Lin; Yuan-Pin Huang; Chun-Hui Su; Je Lo; Yu-Lin Ho; Ching-Yuan Yao; Li-Ching Hsu; Ho-Sheng Wu; Ming-Tsan Liu
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

5.  A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.

Authors:  Jesse D Bloom; Jagannath S Nayak; David Baltimore
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

6.  A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses.

Authors:  Vanessa Escuret; Patrick J Collins; Jean-Sébastien Casalegno; Sebastien G Vachieri; Nicholas Cattle; Olivier Ferraris; Murielle Sabatier; Emilie Frobert; Valérie Caro; John J Skehel; Steve Gamblin; Frédéric Valla; Martine Valette; Michèle Ottmann; John W McCauley; Rodney S Daniels; Bruno Lina
Journal:  J Infect Dis       Date:  2014-05-03       Impact factor: 5.226

7.  Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses.

Authors:  Susu Duan; Elena A Govorkova; Justin Bahl; Hassan Zaraket; Tatiana Baranovich; Patrick Seiler; Kristi Prevost; Robert G Webster; Richard J Webby
Journal:  Nat Commun       Date:  2014-10-09       Impact factor: 14.919

8.  Functional balance between the hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 HA D222 variants.

Authors:  Jean-Sébastien Casalegno; Olivier Ferraris; Vanessa Escuret; Maude Bouscambert; Corinne Bergeron; Laetitia Linès; Thierry Excoffier; Martine Valette; Emilie Frobert; Sylvie Pillet; Bruno Pozzetto; Bruno Lina; Michèle Ottmann
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

Review 9.  Safety and efficacy of peramivir for influenza treatment.

Authors:  Atsuko Hata; Ryoko Akashi-Ueda; Kazufumi Takamatsu; Takuro Matsumura
Journal:  Drug Des Devel Ther       Date:  2014-10-24       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.